Breaking News Instant updates and real-time market news.

FDX

FedEx

$181.27 /

-1.15 (-0.63%)

16:05
03/19/19
03/19
16:05
03/19/19
16:05

FedEx reports Q3 adjusted EPS $3.03, consensus $3.11

Reports Q3 revenue $17B, consensus $17.67B. Reports Q3 adjusted operating margin 5.8% vs 5.8% last year. This year's quarterly consolidated results have been adjusted to exclude TNT Express integration expenses and business realignment costs. Last year's quarterly consolidated results were adjusted to exclude TNT Express integration expenses and the benefit of an estimated $1.15B reduction in the company's net U.S. deferred tax liability attributable to the lower statutory rate enacted as part of the Tax Cuts and Jobs Act.

  • 19

    Mar

  • 01

    Apr

  • 02

    Apr

FDX FedEx
$181.27 /

-1.15 (-0.63%)

03/07/19 Citi
FedEx price target lowered to $210 from $225 at Citi
02/22/19 B. Riley FBR
Stamps.com should return to high single-digit growth, says B. Riley FBR
02/19/19 Morgan Stanley
Morgan Stanley downgrades XPO Logistics, says M&A 'off the table'
02/15/19 JPMorgan
JPMorgan cuts XPO Logistics target to $78, removes from Focus List

TODAY'S FREE FLY STORIES

Hot Stocks
iRadimed announces retirement of VP of regulatory affairs, quality assurance » 07:28
02/26/20
02/26
07:28
02/26/20
07:28
IRMD

iRadimed

$26.22 /

-0.3 (-1.13%)

IRADIMED CORPORATION…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Tonix, Southern Research announce collaboration for coronavirus vaccine » 07:27
02/26/20
02/26
07:27
02/26/20
07:27
TNXP

Tonix Pharmaceuticals

$0.40 /

-0.0228 (-5.36%)

Tonix Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Insulet price target lowered to $205 from $213 at Raymond James » 07:26
02/26/20
02/26
07:26
02/26/20
07:26
PODD

Insulet

$197.03 /

-10.46 (-5.04%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Nike downgraded to Hold on 'stretched' valuation at HSBC » 07:26
02/26/20
02/26
07:26
02/26/20
07:26
NKE

Nike

$92.87 /

-3.03 (-3.16%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
RTI Surgical announces clinical data on SImmetry System » 07:26
02/26/20
02/26
07:26
02/26/20
07:26
RTIX

RTI Surgical

$4.28 /

-0.21 (-4.68%)

RTI Surgical Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Nexstar reports Q4 EPS $2.36, consensus $3.06 » 07:25
02/26/20
02/26
07:25
02/26/20
07:25
NXST

Nexstar

$113.93 /

-2.83 (-2.42%)

Reports Q4 revenue $1.1B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Menlo Therapeutics Inc trading halted, news pending  07:25
02/26/20
02/26
07:25
02/26/20
07:25
MNLO

Menlo Therapeutics

$4.45 /

-0.53 (-10.64%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Horizon Therapeutics sees FY20 revenue view $1.4B-$1.42B, consensus $1.39B  07:25
02/26/20
02/26
07:25
02/26/20
07:25
HZNP

Horizon Therapeutics

$33.82 /

-0.715 (-2.07%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
American Tower price target raised to $273 from $254 at KeyBanc » 07:25
02/26/20
02/26
07:25
02/26/20
07:25
AMT

American Tower

$246.45 /

+1.17 (+0.48%)

KeyBanc analyst Brandon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
CNO Financial to host investor day » 07:25
02/26/20
02/26
07:25
02/26/20
07:25
CNO

CNO Financial

$17.64 /

-0.77 (-4.18%)

Investor day to be held…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Morgan Stanley metals/commodities analysts hold analyst/industry conference call » 07:25
02/26/20
02/26
07:25
02/26/20
07:25

Global Commodity…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
Foot Locker price target lowered to $50 from $65 at Raymond James » 07:24
02/26/20
02/26
07:24
02/26/20
07:24
FL

Foot Locker

$35.31 /

-1.875 (-5.04%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
ProQR Therapeutics expects operations to be funded into 2022 » 07:24
02/26/20
02/26
07:24
02/26/20
07:24
PRQR

ProQR Therapeutics

$7.65 /

-0.81 (-9.57%)

In October 2019, the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Horizon Therapeutics reports Q4 adj. EPS 56c, consensus 42c » 07:24
02/26/20
02/26
07:24
02/26/20
07:24
HZNP

Horizon Therapeutics

$33.82 /

-0.715 (-2.07%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
ProQR Therapeutics expects to advance QR-504a to clinical development in 2020 » 07:23
02/26/20
02/26
07:23
02/26/20
07:23
PRQR

ProQR Therapeutics

$7.65 /

-0.81 (-9.57%)

QR-504a for Fuchs…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
ProQR Therapeutics expects initial data from Phase 2/2 Aurora trial in 2021 » 07:22
02/26/20
02/26
07:22
02/26/20
07:22
PRQR

ProQR Therapeutics

$7.65 /

-0.81 (-9.57%)

QR-1123 for autosomal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
ProQR Therapeutics expects interim data from Phase 2/2 Stellar trial in 1Q20 » 07:22
02/26/20
02/26
07:22
02/26/20
07:22
PRQR

ProQR Therapeutics

$7.65 /

-0.81 (-9.57%)

QR-421a for Usher…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Toll Brothers downgraded to Market Perform at Raymond James after Q1 results » 07:21
02/26/20
02/26
07:21
02/26/20
07:21
TOL

Toll Brothers

$44.28 /

-2.765 (-5.88%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
ProQR Therapeutics expects topline data from Illuminate trial in 1H21 » 07:21
02/26/20
02/26
07:21
02/26/20
07:21
PRQR

ProQR Therapeutics

$7.65 /

-0.81 (-9.57%)

Sepofarsen for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
TopBuild price target raised to $131 from $120 at KeyBanc » 07:21
02/26/20
02/26
07:21
02/26/20
07:21
BLD

TopBuild

$113.86 /

-7.44 (-6.13%)

KeyBanc analyst Kenneth…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
H.C. Wainwright reiterates $51 price target on Amarin shares post Q4 results » 07:20
02/26/20
02/26
07:20
02/26/20
07:20
AMRN

Amarin

$17.54 /

-0.05 (-0.28%)

, RDY

Dr. Reddy's

$42.70 /

-0.89 (-2.04%)

, HKMPY

Hikma

$0.00 /

+ (+0.00%)

, TEVA

Teva

$13.25 /

+0.55 (+4.33%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
E-Trade downgraded at Raymond James following sale announcement » 07:20
02/26/20
02/26
07:20
02/26/20
07:20
ETFC

E-Trade

$48.52 /

-1.88 (-3.73%)

, MS

Morgan Stanley

$48.02 /

-1.65 (-3.32%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Summit Therapeutics appoints Robert Duggan as executive chairman » 07:20
02/26/20
02/26
07:20
02/26/20
07:20
SMMT

Summit Therapeutics

$1.35 /

-0.06 (-4.26%)

Summit Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Earnings
Element Solutions sees FY20 adj. EPS 93c-97c, consensus 95c  07:19
02/26/20
02/26
07:19
02/26/20
07:19
ESI

Element Solutions

$10.66 /

-0.62 (-5.50%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Carrols Restaurant price target lowered to $9 from $12 at SunTrust » 07:19
02/26/20
02/26
07:19
02/26/20
07:19
TAST

Carrols Restaurant

$4.94 /

-0.19 (-3.70%)

SunTrust analyst Jake…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.